Abrupt Cessation of Lorazepam: Withdrawal Symptoms
Abruptly stopping lorazepam can cause a dangerous withdrawal syndrome including anxiety, agitation, tremors, headaches, sweating, insomnia, nausea, vomiting, muscle cramps, hyperactive delirium, and potentially life-threatening seizures or death. 1, 2, 3
Critical Withdrawal Symptoms
The FDA drug label for Ativan (lorazepam) explicitly warns that abrupt discontinuation can precipitate acute withdrawal reactions that can be life-threatening, including seizures 3. The withdrawal syndrome manifests through multiple organ systems:
Neuropsychiatric Symptoms
- Anxiety and agitation (often severe, rebound anxiety exceeding baseline) 1
- Tremors and myoclonus 1
- Hyperactive delirium 1
- Hallucinations 2
- Seizures (grand mal seizures documented even after therapeutic doses) 1, 2, 4, 5
- Delirium tremens 2, 6, 2
- Confusion and altered mental status 3
- Depression and irritability 3, 7
Physical Symptoms
- Insomnia and sleep disturbances (rebound insomnia can be severe) 1, 8, 9
- Headaches 1
- Sweating 1
- Nausea and vomiting 1
- Muscle cramps and stiffness 1, 7
- Tachycardia and hypertension 3, 7
- Gastrointestinal distress (dry wretching, diarrhea, weight loss) 3, 7
Severe and Life-Threatening Complications
The most critical risk is that benzodiazepine withdrawal can result in death 2, 6, 2, 3, 10. The 2016 CDC Guideline explicitly states that "abrupt withdrawal can be associated with rebound anxiety, hallucinations, seizures, delirium tremens, and, in rare cases, death" 2. This is corroborated by case reports documenting fatal outcomes from benzodiazepine withdrawal 10.
Timeline and Risk Factors
Withdrawal symptoms typically emerge within 1-4 days after discontinuation, though the exact timing depends on lorazepam's intermediate half-life 7. The severity peaks around the third withdrawal night for sleep disturbances 8, 9.
Higher risk patients include those who:
- Have taken higher doses or used lorazepam more frequently than recommended 3
- Have been on prolonged treatment (days to weeks) 1, 3
- Abruptly discontinue rather than taper 2, 3
- Have concurrent use of other CNS depressants 2
Notably, withdrawal seizures have been documented even with therapeutic doses used for less than 15 days 5, and after as little as 7 nights of use 8.
Protracted Withdrawal Syndrome
Beyond acute withdrawal, some patients develop protracted withdrawal syndrome lasting weeks to more than 12 months, characterized by persistent anxiety, cognitive impairment, depression, insomnia, motor symptoms (weakness, tremor, muscle twitches), paresthesia, and tinnitus 3.
Critical Management Principle
Never abruptly discontinue lorazepam. The 2016 CDC Guideline recommends a gradual taper, typically reducing the dose by 25% every 1-2 weeks 2. The FDA label emphasizes that for patients using lorazepam more frequently than recommended, "use a gradual taper to discontinue" to reduce the risk of withdrawal reactions 3.
Important Caveat
Administration of flumazenil (a benzodiazepine antagonist) can precipitate acute withdrawal and should be avoided in patients with chronic benzodiazepine exposure 1, 3.
Comparison to Other Withdrawal Syndromes
The 2016 CDC Guideline notes that benzodiazepine withdrawal carries greater risks than opioid withdrawal 2, 6. When patients are on both medications, it may be safer to taper opioids first, then address benzodiazepine tapering separately with appropriate support 2.